Ensign Peak Advisors’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $423K | Hold |
13,385
| – | – | ﹤0.01% | 1598 |
|
|
2025
Q1 | $444K | Hold |
13,385
| – | – | ﹤0.01% | 1578 |
|
|
2024
Q4 | $461K | Hold |
13,385
| – | – | ﹤0.01% | 1621 |
|
|
2024
Q3 | $535K | Hold |
13,385
| – | – | ﹤0.01% | 1588 |
|
|
2024
Q2 | $404K | Hold |
13,385
| – | – | ﹤0.01% | 1649 |
|
|
2024
Q1 | $449K | Sell |
13,385
-675
| -5% | -$22.7K | ﹤0.01% | 1645 |
|
|
2023
Q4 | $454K | Buy |
14,060
+2,350
| +20% | +$75.9K | ﹤0.01% | 1674 |
|
|
2023
Q3 | $384K | Hold |
11,710
| – | – | ﹤0.01% | 1651 |
|
|
2023
Q2 | $412K | Hold |
11,710
| – | – | ﹤0.01% | 1671 |
|
|
2023
Q1 | $382K | Buy |
11,710
+300
| +3% | +$9.8K | ﹤0.01% | 1685 |
|
|
2022
Q4 | $629K | Buy |
11,410
+7,150
| +168% | +$394K | ﹤0.01% | 1527 |
|
|
2022
Q3 | $189K | Buy |
4,260
+880
| +26% | +$39K | ﹤0.01% | 1894 |
|
|
2022
Q2 | $165K | Hold |
3,380
| – | – | ﹤0.01% | 1850 |
|
|
2022
Q1 | $164K | Buy |
3,380
+3,090
| +1,066% | +$150K | ﹤0.01% | 1932 |
|
|
2021
Q4 | $12K | Buy |
+290
| New | +$12K | ﹤0.01% | 2187 |
|